SEP 17, 2024 | US | AGENCY SUBMISSION
US: Joint Letter to Congress re PREVAIL Act
We strongly urge you to oppose the Promoting and Respecting Economically Vital American Innovation Leadership Act (the “PREVAIL Act”), which was recently placed on the markup agenda. This bill would further weaken protections against abusive patent litigation, create unjustified obstacles to PTAB review, substantially degrade the performance of the PTAB, and significantly reduce patent quality and the ability of the patent system to promote technological progress.
Descargar PDFEQUIPO DE POLÍTICAS GLOBALES
Haga clic para ver el personal de políticas dedicado de BSA en todo el mundo.